World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
19263
World Ranking
17722
National Ranking
8846

Neuroscience

D-Index
79
Citations
19236
World Ranking
1709
National Ranking
831

Patricia J. McLaughlin publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Patricia J. McLaughlin sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 420 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Patricia J. McLaughlin D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Patricia J. McLaughlin sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 79 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Patricia J. McLaughlin is affiliated with Pennsylvania State University in the United States. Their research primarily spans the fields of Medicine and Neuroscience, with a notable focus on subfields such as Neurology, Public Health, Environmental and Occupational Health, Cellular and Molecular Neuroscience, Physiology, and Pathology and Forensic Medicine.

The scientist's work covers several main topics, including:

  • Ocular Surface and Contact Lens
  • Multiple Sclerosis Research Studies
  • Neuropeptides and Animal Physiology
  • Pain Mechanisms and Treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Immune Cell Function and Interaction
  • Cancer, Stress, Anesthesia, and Immune Response

Noteworthy recent publications by Patricia J. McLaughlin include:

  • Dysregulation of the OGF-OGFr pathway correlates with elevated serum OGF and ocular surface complications in the diabetic rat, 2020, Experimental Biology and Medicine
  • Blockade of OGFr delays the onset and reduces the severity of diabetic ocular surface complications, 2020, Experimental Biology and Medicine
  • Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin, 2021, Biochemical Pharmacology
  • Low-dose naltrexone reduced anxiety in persons with multiple sclerosis during the COVID-19 pandemic, 2022, International Immunopharmacology
  • [Met5]-enkephalin preserves diffusion metrics in EAE mice, 2020, Brain Research Bulletin

Frequent coauthors collaborating with Patricia J. McLaughlin include:

  • Ian S. Zagon
  • Joseph W. Sassani
  • Indira Purushothaman
  • Gary A. Thomas
  • Laura Odom

The scientist has published extensively in several venues, including:

  • Experimental Biology and Medicine
  • Journal of Diabetes and Clinical Research
  • Medical Research Archives
  • Neurochemical Research
  • Biochemical Pharmacology

Best Publications

  • Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma

    N. L. Berinstein;A. J. Grillo-Lopez;C. A. White;I. Bence-Bruckler

  • The biology of the opioid growth factor receptor (OGFr).

    Ian S Zagon;Michael F Verderame;Patricia J McLaughlin

  • Increased brain size and cellular content in infant rats treated with an opiate antagonist

    Ian S. Zagon;Patricia J. McLaughlin

  • Naltrexone modulates tumor response in mice with neuroblastoma

    Ian S. Zagon;Patricia J. McLaughlin

  • Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system.

    Ian S. Zagon;Patricia J. McLaughlin

  • Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival

    A. H. Sarris;K.-O. Kliche;P. Pethambaram;A. Preti

  • A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.

    F. Swan;W. S. Velasquez;Susan L Tucker;J. R. Redman

  • Liposomal vincristine in relapsed non-Hodgkin's lymphomas: Early results of an ongoing phase II trial

    A.H. Sarris;F. Hagemeister;J. Romaguera;M.A. Rodriguez

  • Naltrexone modulates body and brain development in rats: A role for endogenous opioid systems in growth

    Ian S. Zagon;Patricia J. McLaughlin

  • Opioids and the apoptotic pathway in human cancer cells

    Ian S Zagon;Patricia J McLaughlin

  • Rituximab in indolent lymphoma: the single-agent pivotal trial.

    P. McLaughlin;F. B. Hagemeister;A. J. Grillo-Lopez

  • Distribution of Enkephalin Immunoreactivity in Germinative Cells of Developing Rat Cerebellum

    Ian S. Zagon;Randall E. Rhodes;Patricia J. McLaughlin

  • Endogenous opioids regulate dendritic growth and spine formation in developing rat brain.

    Kurt F. Hauser;Patricia J. McLaughlin;Ian S. Zagon

  • Endogenous opioid systems and the regulation of dendritic growth and spine formation

    Kurt F. Hauser;Patricia J. McLaughlin;Ian S. Zagon

  • MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease.

    F. B. Hagemeister;Nizar M Tannir;P. McLaughlin;P. Salvador

  • Opioid receptors and endogenous opioids in diverse human and animal cancers.

    Ian S. Zagon;Patricia J. McLaughlin;Steven R. Goodman;Randy E. Rhodes

  • Immunolocalization of tumour necrosis factor-α (TNF-α) in the placental bed of normotensive and hypertensive human pregnancies

    R. Pijnenborg;P.J. McLaughlin;L. Vercruysse;M. Hanssens

  • Opioid growth factor modulates angiogenesis

    Ian Zagon;John Blebea;Patricia McLaughlin

  • Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus.

    Ian S. Zagon;Matthew S. Klocek;Joseph W. Sassani;Patricia J. McLaughlin

  • Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.

    Maria A Rodriguez;F. C. Cabanillas;W. Velasquez;F. B. Hagemeister

  • Clinical Status and Optimal Use of Rituximab for B-Cell Lymphomas

    P McLaughlin;C A White;A J Grillo-López;D G Maloney

Frequent Co-Authors

Ian S. Zagon
Ian S. Zagon Pennsylvania State University
Fernando Cabanillas
Fernando Cabanillas The University of Texas MD Anderson Cancer Center
Fredrick B. Hagemeister
Fredrick B. Hagemeister The University of Texas MD Anderson Cancer Center
Steven R. Goodman
Steven R. Goodman University of Tennessee Health Science Center
Luis Fayad
Luis Fayad The University of Texas MD Anderson Cancer Center
Alan G. Weeds
Alan G. Weeds MRC Laboratory of Molecular Biology
Borje S. Andersson
Borje S. Andersson The University of Texas MD Anderson Cancer Center
David T. Mauger
David T. Mauger Pennsylvania State University
David M. Goldenberg
David M. Goldenberg Immunomedics (United States)
Issa F. Khouri
Issa F. Khouri The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience opens the door to a variety of online degree options and career pathways in related fields. Many students consider an accredited online psychology degree for foundational knowledge and flexible learning. These programs offer a balance between academic rigor and affordability, making them accessible to a wider range of learners.

If you're interested in clinical support roles, pursuing the easiest msw program online can fast-track your entry into social work, combining neuroscience insights with community impact. Similarly, those aiming for advanced mental health care positions might explore online psyd clinical psychology programs, which emphasize hands-on clinical training and research.

For a quicker route to professional licensure, accelerated mft programs deliver specialized skills for marriage and family therapy. Each pathway offers flexibility and a focused curriculum, helping you align your neuroscience background with rewarding careers in mental health and social services.

Best Scientists Citing Patricia J. McLaughlin

Trending Scientists

Recently Published Articles